Zeneca
Zeneca was a British multinational pharmaceutical company, established in 1993 through the demerger of the pharmaceutical operations from ICI. It was later merged with the Swedish company Astra AB in 1999 to form AstraZeneca.
History[edit | edit source]
Zeneca was formed in June 1993 by the demerger of the pharmaceuticals and agrochemicals businesses of ICI into a separate company. The decision to demerge was taken due to the increasing divergence between the business models of the pharmaceutical and bulk chemicals businesses. The demerger was also part of a broader trend of companies spinning off their pharmaceutical operations to focus on core businesses.
In 1999, Zeneca and Astra AB announced their intention to merge, with the new company to be called AstraZeneca. The merger was completed in April 1999, creating the third largest pharmaceutical company in the world.
Products[edit | edit source]
Zeneca developed and marketed a wide range of pharmaceutical products. These included oncology drugs such as tamoxifen, used in the treatment of breast cancer, and Zoladex, used in the treatment of prostate cancer. It also produced cardiovascular drugs such as Atenolol, used in the treatment of high blood pressure, and Seloken, used in the treatment of angina and heart failure.
Research and Development[edit | edit source]
Zeneca was known for its strong commitment to research and development. It invested heavily in the development of new drugs and treatments, with a particular focus on oncology, cardiovascular diseases, and gastroenterology. Its research efforts led to the development of several breakthrough drugs, including the first selective estrogen receptor modulator, tamoxifen.
Legacy[edit | edit source]
The legacy of Zeneca continues in the form of AstraZeneca, which has become one of the world's leading pharmaceutical companies. Many of the drugs developed by Zeneca continue to be marketed by AstraZeneca and are used in the treatment of a wide range of conditions.
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
